FHA
NVIV

Flagship Harbor Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Flagship Harbor Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Hold
0
– – – 2012
2020
Q3 		– Hold
0
– – – 2254
2020
Q2 		– Hold
0
– – – 2236
2020
Q1 		– Hold
0
– – – 2048
2019
Q4 		– Hold
0
– – – 2009
2019
Q3 		– Hold
0
– – – 2044
2019
Q2 		– Hold
0
– – – 2039
2019
Q1 		– Hold
0
– – – 2025
2018
Q4 		– Hold
0
– – – 2225
2018
Q3 		– Hold
0
– – – 2188
2018
Q2 		– Hold
0
– – – 2115
2017
Q4 		– Sell
-1
Closed -$21K – 389
2017
Q3 		$21K Hold
1
– – 0.01% 343
2017
Q2 		$34K Hold
1
– – 0.01% 341
2017
Q1 		$62K Hold
1
– – 0.02% 320
2016
Q4 		$69K Buy
+1
New +$89.4K 0.03% 285

Other funds holding NVIV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Flagship Harbor Advisors's NVIV Position: Q4 2020 in Review

Flagship Harbor Advisors held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q4 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Flagship Harbor Advisors first reported a position in NVIV in Q4 2016 and has held it in 4 quarters since. The position peaked at $69K in Q4 2016. 11 funds tracked by Wall St. Rank hold NVIV as of Q4 2020.

  • Flagship Harbor Advisors held 0 shares of InVivo Therapeutics Holdings Corp worth $0 as of Q4 2020.
  • Flagship Harbor Advisors left its InVivo Therapeutics Holdings Corp share count unchanged in Q4 2020.
  • InVivo Therapeutics Holdings Corp made up ﹤0.01% of Flagship Harbor Advisors's portfolio in Q4 2020, its #2012 holding.
  • Flagship Harbor Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q4 2016 and has held it in 4 quarters since.
  • Flagship Harbor Advisors's InVivo Therapeutics Holdings Corp position peaked at $69K in Q4 2016.
  • 11 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.